Zika Virus Infection: An Emergency of International Concern

The Zika virus (ZIKV) is an arbovirus, meaning that it is insect vector-borne disease, most commonly transmitted through Aedes mosquitoes. ZIKV was first identified in Uganda in 1947 in monkeys through a network that monitored yellow fever. It was later identified in humans. ZIKV is endemic to parts of Africa and Asia, but over the past months, a large number of locally acquired cases have been discovered in Brazil. The number of cases and the locations of the outbreak qualify ZIKV as a rapidly growing epidemic threat. The ZIKV causes microcephaly, small heads and often damaged brains, which may not have developed properly during pregnancy or may have stopped growing in the first years of life. These children may experience a range of problems, like developmental delays, intellectual deficits or hearing loss. Until recently, Zika was not considered a major threat because its symptoms are relatively mild. There is no widely available test for Zika infection. Infection with Zika virus may be suspected based on symptoms and recent history of travel. A diagnosis of Zika virus infection can only be confirmed through laboratory tests on blood or other body fluids, such as urine, saliva or semen. Protection against mosquito bites is a key measure to prevent Zika virus infection. You can submit your Manuscripts at: https://symbiosisonlinepublishing.com/submitManuscript.php